- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2024 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Pharmaceutical Technology-10-02-2008
Pharmaceutical Technology
Putting Together the Pieces
October 02, 2008
Special Report
32
10
Several strategies and software applications help pharmaceutical companies integrate their manufacturing execution systems and enterprise resource planning systems.
Integration the Easy Way
October 02, 2008
Online Exclusive
32
10
Pharmaceutical companies want software vendors to make integrating manufacturing execution systems and enterprise resource planning systems easier.
A Case for Developing a Standards-Based Approach to Plug-and-Play Equipment
October 02, 2008
Viewpoint
32
10
Industry needs a standard to connect systems and equipment sooner rather than later.
Effect of Binder Type and Binder Level on the Properties of Agglomerates Containing Lactose and Dibasic Calcium Phosphate Dihydrate
October 02, 2008
Peer-Reviewed Research
32
10
The authors studied the effect of the combination of binders on the flow and compressibility characteristics of the agglomerates of binary combination of lactose and dibasic calcium phosphate dihydrate.
EC Reviews: An Executive Country Review on Turkey
October 02, 2008
Articles
32
10
In the wake of economic growth, healthcare reforms, and large-scale industry investment, Turkish pharmaceutical companies are charting their own destiny.
Continuous Mixing of Solid Dosage Forms via Hot-Melt Extrusion
October 02, 2008
Articles
32
10
The author describes the benefits, processes, and practicality of using hot-melt extrusion to mix active pharmaceutical ingredients with pharmaceutical-grade polymers.
Trends: NAS Launches and NME Approvals Rise and Fall
October 02, 2008
News
32
10
A recent report shows a decline in NASs and a rise in NME applications in 2007.
To-Do List for 2009
October 02, 2008
Online Exclusive
32
10
Planning ahead will ensure successful efforts to improve packaging and packaging operations.
Complex Science
October 02, 2008
PharmTech Talk
32
10
Advancements add yet another challenge for industry's already overextended regulatory body.
Review of Changes in Topical Drug Product Classification
October 02, 2008
Peer-Reviewed Research
32
10
This article summarizes the classification systems for topical liquid and semisolid dosage forms used for dermatological application and notes some differences between FDA and USP classification.
Human After All
October 02, 2008
Agent-In-Place
32
10
To err may be human, but to really mess things up, you need management.
Outsourcing Strategies of Emerging Pharma
October 02, 2008
Ingredients Insider
32
10
Emerging pharmaceutical companies represent an important client base for CROs and CMOs. Lessons learned for successful customer–supplier relations.
FDA Proposes Flexible Oversight for Quality Systems
October 02, 2008
Washington Report
32
10
Manufacturers seek real-world benefits from investment in QbD and risk-management strategies. This article contains bonus online-exclusive material.
Report From: Europe
October 02, 2008
News
32
10
Although the European Union's approval rates of biosimilars for market is increasing slower than expected, its approach may provide an example for other foreign markets.
The Past as Prologue
October 02, 2008
From The Editor
32
10
Can previous trends of Democratic and Republican administrations predict industry's future?
Are You Ready for REMS?
October 02, 2008
Online Exclusive
32
10
A book offers a detailed introduction to the new area of risk evaluation and mitigation strategies.
In the Spotlight October 2008
October 02, 2008
In the Spotlight
32
10
Editors' Picks of Pharmaceutical Science & Technology Innovations
Peer-Reviewed Technical Note: Quality by Design in Freeze-Drying
October 02, 2008
Peer-Reviewed Research
32
10
Cycle design and robustness testing using advanced process analytical technology.
Minding Your P's and Q's
October 02, 2008
Outsourcing Outlook
32
10
As offshore savings decline, pharmaceutical companies still have a lot of work to do to reduce costs.